We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62B
AUM Growth
+$4.39B
Cap. Flow
-$1.97B
Cap. Flow %
-3.18%
Top 10 Hldgs %
43.7%
Holding
1,103
New
130
Increased
284
Reduced
500
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$218M
2
PH icon
Parker-Hannifin
PH
+$155M
3
ILMN icon
Illumina
ILMN
+$80.7M
4
DIS icon
Walt Disney
DIS
+$74.2M
5
AZEK
The AZEK Co
AZEK
+$56.4M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$819M
2
META icon
Meta Platforms (Facebook)
META
+$338M
3
MSFT icon
Microsoft
MSFT
+$131M
4
AMZN icon
Amazon
AMZN
+$106M
5
CRM icon
Salesforce
CRM
+$93.2M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Communication Services 16.35%
3 Consumer Discretionary 16.22%
4 Healthcare 12.62%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLM icon
826
SLM Corp
SLM
$5.15B
$5K ﹤0.01%
+283
New +$4.31K
SOFI icon
827
SoFi Technologies
SOFI
$23.7B
$5K ﹤0.01%
547
-1,084
-66% -$7.07K
SRPT icon
828
Sarepta Therapeutics
SRPT
$1.77B
$5K ﹤0.01%
41
+13
+46% +$1.68K
TDOC icon
829
Teladoc Health
TDOC
$1.3B
$5K ﹤0.01%
+193
New +$4.86K
U icon
830
Unity
U
$18.9B
$5K ﹤0.01%
+111
New +$3.55K
UHAL icon
831
U-Haul Holding Co
UHAL
$14.6B
$5K ﹤0.01%
92
-101
-52% -$5.92K
XYL icon
832
Xylem
XYL
$28.1B
$5K ﹤0.01%
48
-57
-54% -$6.03K
PYCR
833
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$5K ﹤0.01%
+201
New +$4.69K
ADT icon
834
ADT
ADT
$5.58B
$4K ﹤0.01%
683
ARW icon
835
Arrow Electronics
ARW
$10.4B
$4K ﹤0.01%
27
-81
-75% -$10.1K
CC icon
836
Chemours
CC
$2.37B
$4K ﹤0.01%
+109
New +$3.33K
CE icon
837
Celanese
CE
$4.82B
$4K ﹤0.01%
+31
New +$3.36K
CEG icon
838
Constellation Energy
CEG
$95.6B
$4K ﹤0.01%
41
-85
-67% -$7.05K
CPRT icon
839
Copart
CPRT
$27.5B
$4K ﹤0.01%
+86
New +$3.56K
CRUS icon
840
Cirrus Logic
CRUS
$6.26B
$4K ﹤0.01%
45
-108
-71% -$8.94K
CTSH icon
841
Cognizant
CTSH
$26B
$4K ﹤0.01%
+55
New +$3.41K
DASH icon
842
DoorDash
DASH
$93.7B
$4K ﹤0.01%
+51
New +$3.38K
DBX icon
843
Dropbox
DBX
$8.12B
$4K ﹤0.01%
+150
New +$3.42K
DNA icon
844
Ginkgo Bioworks
DNA
$521M
$4K ﹤0.01%
+59
New +$3.49K
DV icon
845
DoubleVerify
DV
$2.03B
$4K ﹤0.01%
114
-818
-88% -$26.4K
GH icon
846
Guardant Health
GH
$22.6B
$4K ﹤0.01%
+124
New +$3.56K
GM icon
847
General Motors
GM
$76.8B
$4K ﹤0.01%
94
-240
-72% -$8.3K
LEN icon
848
Lennar Class A
LEN
$21.2B
$4K ﹤0.01%
+31
New +$3.38K
MOS icon
849
The Mosaic Company
MOS
$7.33B
$4K ﹤0.01%
116
-111
-49% -$4.29K
MP icon
850
MP Materials
MP
$9.1B
$4K ﹤0.01%
191
-147
-43% -$3.37K

Similar funds

Loomis, Sayles & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Loomis, Sayles & Company held 1,103 positions worth $62B, up 7.6% from $57.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Loomis, Sayles & Company withdrew a net $1.97B in Q2 2023, closing 130 positions and reducing 500 holdings. Its most notable exit was Halozyme, an estimated $81.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in The AZEK Co worth $66.1M.

  • Loomis, Sayles & Company's largest Q2 2023 buy was The AZEK Co: 2,181,837 shares worth $66.1M.
  • Loomis, Sayles & Company added most to Tesla in Q2 2023, an estimated $218M increase.
  • Loomis, Sayles & Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $819M.
  • Loomis, Sayles & Company fully exited Halozyme in Q2 2023, selling an estimated $81.3M.
  • Loomis, Sayles & Company's ten largest holdings make up 44% of its $62B portfolio in Q2 2023.
  • Loomis, Sayles & Company opened 130 new positions and closed 130 in Q2 2023.
  • Loomis, Sayles & Company's portfolio value rose 7.6% quarter-over-quarter to $62B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.